57 related articles for article (PubMed ID: 9823840)
1. Successful prevention of retrocochlear hearing loss in murine experimental allergic encephalomyelitis with T cell receptor Vbeta8-specific antibody.
Suzuki M; Cheng KC; Krug MS; Yoo TJ
Ann Otol Rhinol Laryngol; 1998 Nov; 107(11 Pt 1):917-27. PubMed ID: 9823840
[TBL] [Abstract][Full Text] [Related]
2. Brain stem auditory-evoked potentials of mice with experimental allergic encephalomyelitis.
Watanabe T; Cheng KC; Krug MS; Yoo TJ
Ann Otol Rhinol Laryngol; 1996 Nov; 105(11):905-15. PubMed ID: 8916868
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies.
Zaller DM; Osman G; Kanagawa O; Hood L
J Exp Med; 1990 Jun; 171(6):1943-55. PubMed ID: 1693655
[TBL] [Abstract][Full Text] [Related]
4. A natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis.
Fernández-Malavé E; Stark-Aroeira L
J Neuroimmunol; 2011 May; 234(1-2):63-70. PubMed ID: 21396721
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector.
Chunduru SK; Sutherland RM; Stewart GA; Doms RW; Paterson Y
J Immunol; 1996 Jun; 156(12):4940-5. PubMed ID: 8648145
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of T-cell receptor beta gene segment in the retrocochlear lesions of EAE mice.
Cheng KC; Lee KM; Yoo TJ
ORL J Otorhinolaryngol Relat Spec; 1998; 60(3):126-32. PubMed ID: 9579355
[TBL] [Abstract][Full Text] [Related]
7. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
8. Connexin 43 and hearing: possible implications for retrocochlear auditory processing.
Kim AH; Nahm E; Sollas A; Mattiace L; Rozental R
Laryngoscope; 2013 Dec; 123(12):3185-93. PubMed ID: 23817980
[TBL] [Abstract][Full Text] [Related]
9. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone's effect in the retrocochlear auditory centers of a noise-induced hearing loss mouse model.
Chen L; Dean C; Gandolfi M; Nahm E; Mattiace L; Kim AH
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):667-74. PubMed ID: 25113508
[TBL] [Abstract][Full Text] [Related]
11. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.
Zhou SR; Whitaker JN
J Immunol; 1993 Feb; 150(4):1629-42. PubMed ID: 7679432
[TBL] [Abstract][Full Text] [Related]
12. Clinical thresholds for when to test for retrocochlear lesions: pro.
Cueva RA
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):725-7. PubMed ID: 20644070
[No Abstract] [Full Text] [Related]
13. Prevention and treatment of Lewis rat experimental allergic encephalomyelitis with a monoclonal antibody to the T cell receptor V beta 8.2 segment.
Imrich H; Kugler C; Torres-Nagel N; Dörries R; Hünig T
Eur J Immunol; 1995 Jul; 25(7):1960-4. PubMed ID: 7542597
[TBL] [Abstract][Full Text] [Related]
14. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
15. Murine model of autoimmune hearing loss induced by myelin protein P0.
Matsuoka H; Cheng KC; Krug MS; Yazawa Y; Yoo TJ
Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):255-64. PubMed ID: 10086618
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
Johns LD; Flanders KC; Ranges GE; Sriram S
J Immunol; 1991 Sep; 147(6):1792-6. PubMed ID: 1716279
[TBL] [Abstract][Full Text] [Related]
17. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage.
Kuchroo VK; Sobel RA; Laning JC; Martin CA; Greenfield E; Dorf ME; Lees MB
J Immunol; 1992 Jun; 148(12):3776-82. PubMed ID: 1376341
[TBL] [Abstract][Full Text] [Related]
18. Differences between two strains of myelin basic protein (MBP) TCR transgenic mice: implications for tolerance induction.
Song F; Wardrop RM; Gienapp IE; Stuckman SS; Goverman J; Whitacre CC
J Autoimmun; 2002 Feb; 18(1):27-37. PubMed ID: 11869044
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
20. Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat.
Chan A; Gold R; Giegerich G; Herrmann T; Jung S; Toyka KV; Hartung HP
J Neurosci Res; 1999 Oct; 58(2):214-25. PubMed ID: 10502278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
